YWYu Wang

Yu Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu Wang has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Jingxiao Li

    Department of Epidemiology and Health Statistics, Shenyang Medical College, Shenyang, Liaoning, China

    3 shared publications
  • Siwei Chao

    Department of Thoracic Surgery, Shenyang Chest Hospital

    3 shared publications
  • Yuchen Gao

    Department of Epidemiology and Health Statistics, Shenyang Medical College, Shenyang, Liaoning, China

    3 shared publications
  • Xiaohui Ren

    Department of Epidemiology and Health Statistics, Shenyang Medical College, Shenyang, Liaoning, China

    2 shared publications
  • Yi Sui

    Department of Neurology, The Fourth People’s Hospital of Shenyang, China Medical University (Y.S.).

    2 shared publications
  • Zihui Yu

    Department of Epidemiology and Health Statistics, Shenyang Medical College, Shenyang, Liaoning, China

    2 shared publications

Latest Publications

  • Open Access

    Preoperative evaluation of solitary pulmonary nodules and adenocarcinoma invasiveness using ultra-high-resolution computed tomography and multidimensional liquid biopsy: a prospective exploratory study

    by Zhengjun Li, Siwei Chao, Ding Li, Chang Liu, Yadong Wang, Guofeng Zhang, Sibo You, Xiaohui Zhang, Yu Wang, Yi Ren

    Background: Accurate preoperative characterization of solitary pulmonary nodules (SPNs), particularly differentiation of benign from malignant lesions and assessment of adenocarcinoma invasiveness, remains challenging based on morphological features alone. We investigated whether integrating 1024-matrix ultra-high-resolution computed tomography (UHRCT) with two liquid-biopsy signals, urinary cellular energy metabolism (CEM) and a seven tumor-associated autoantibody (7-TAAb) panel, could improve diagnostic performance in surgically treated patients with SPNs. Methods: In this single-center prospective study, consecutive adults with SPNs (≤3 cm) scheduled for video-assisted thoracoscopic surgery between January 2022 and December 2024 were enrolled (n = 183). All patients underwent preoperative UHRCT (1024×1024), urinary CEM testing, and 7-TAAb testing. A paired subgroup (n = 85) additionally underwent conventional HRCT (512×512) within 1 month before surgery. Postoperative histopathology served as the reference standard. Diagnostic performance metrics were calculated for each modality, parallel-rule combined strategies, and probability-based logistic regression models. Results: Among 183 patients, 164 (89.6%) had malignant nodules. UHRCT achieved the best single-modality discrimination (AUC, 0.831; sensitivity, 87.2%; specificity, 78.9%), outperforming CEM (AUC, 0.605) and 7-TAAbs (AUC, 0.558). Under the parallel-rule strategy, multimodal testing increased sensitivity but markedly reduced specificity (sensitivity 98.8%, specificity 9.5%). The probability-based fully integrated model achieved the highest AUC (0.946). At the Youden-index threshold of 0.816, this model yielded sensitivity of 92.7%, specificity of 84.2%, PPV of 98.1%, NPV of 57.1%, and accuracy of 91.8%. In the paired comparison (n = 85), UHRCT showed higher sensitivity (92.0% vs. 68.0%) and specificity (90.0% vs. 73.3%) than HRCT. For invasiveness assessment, positivity rates of both urinary CEM (57.6% vs. 31.6%) and 7-TAAbs (53.8% vs. 31.0%) were higher in invasive adenocarcinoma than in pre-invasive lesions. Conclusion: In surgically selected patients with SPNs, 1024-matrix UHRCT provided the strongest single-modality diagnostic information, while urinary CEM and 7-TAAbs offered complementary biological signals associated with invasive adenocarcinoma pathology. Probability-based integration provided a more balanced diagnostic framework than a simple parallel-rule strategy. Given the high prevalence of malignancy and the limited number of benign lesions, these findings should be considered exploratory and require external validation in broader outpatient and screening cohorts.

  • Open Access

    Analysis of factors influencing patient delay in tuberculosis patients in Northeast China: surveillance data from 2015 to 2024

    by Yuchen Gao, Jingxiao Li, Jiying Ma, Zihui Yu, Xiaohui Ren, Siwei Chao, Nan Wang, Jie Liu, Yu Wang

    Tuberculosis (TB) remains a serious challenge to China’s public health, and timely detection and diagnosis of play key roles in preventing disease spread and deterioration. The aim of this study was to understand the delay in consultation for TB patients in Shenyang City, Liaoning Province, and to determine the factors that influence this delay. Delay in consultation was analysed retrospectively in Shenyang City, Liaoning Province. Basic information on TB patients from January 1, 2015, to December 31, 2024, was extracted from the China Tuberculosis Information Management System (TBIMS). The median and interquartile spacing were used for statistical description, and the chi-square test and binary logistic regression model were used to analyse the influencing factors. A total of 38,928 TB patients were included. The median duration of delay in consultation was 18 (6,36) days, and 22,051 (56.65%) patients experienced a delay in consultation, with an increasing trend in the rate of delay in consultation in Shenyang City from 2015 to 2024 (χ2 = 2235.857, P < 0.001). The study revealed that women (OR = 1.185, 95% CI: 1.130 − 1.243), patients aged ≥ 60 years old (OR = 1.218, 95% CI: 1.018 ~ 1.458), patients from ethnic minorities (OR = 1.409, 95% CI: 1.252 − 1.585), and patients who were positive for pathology (OR = 1.296, 95% CI: 1.194 − 1.407) had a greater risk of delay. Among the population categories, farmers had a greater risk of delayed visits. Intracity mobility (OR = 0.573, 95% CI: 0.540 − 0.608) and patient origin as a Physical examination (OR = 0.468, 95% CI: 0.276 − 0.794) were protective factors for visit delay. The rate of delayed visits for TB in Shenyang City from 2015 to 2024 generally increased, and delayed visits were more common. Intervention strategies should be implemented for risk factors and key populations to reduce patients’ suffering and economic losses. Not applicable. The online version contains supplementary material available at 10.1186/s12879-026-12838-1.


  • Open Access

    Burden and trends of cardiovascular diseases attributable to high LDL-C in China, 1990–2021: an age-period-cohort analysis with projectioans to 2050

    by Jingxiao Li, Yuchen Gao, Mengyue Ren, Zihui Yu, Xiaohui Ren, Siwei Chao, Yudong Wu, Mingyue Ma, Yu Wang

    Objective: To analyze the changing trend of the burden of cardiovascular diseases (CVD) caused by high low-density lipoprotein cholesterol (LDL-C) among Chinese residents from 1990 to 2021, as well as the variations in CVD burden by age, period, and cohort, and to predict the trend of CVD burden in 2050, providing a reference for the formulation of CVD prevention strategies in China. Methods: Data on CVD caused by high LDL-C in China from 1990 to 2021 were collected from the Global Burden of Disease (GBD) database. Age-standardized mortality rate (ASMR) and age-standardized disability-adjusted life years rate (ASDR) were obtained to assess the burden of CVD. The Joinpoint model was used to calculate the average annual percentage change (AAPC) of CVD burden and analyze the changing trends of disease burden by gender. The Age-Period-Cohort (APC) model was employed to explore the relationships among age, period, and cohort factors in CVD burden. The Auto Regressive Integrated Moving Average (ARIMA) model was applied to predict the trend of CVD burden in 2050. Results: In 2021, the total number of CVD deaths caused by high LDL-C in China reached 832,884.39(424,042.39–1,289,266.00), a significant increase of 194.37% compared to 1990. The disability-adjusted life years (DALYs) were 18,407,759 (95% UI: 10,268,061–27,106,771), a substantial increase of 132.86% compared to 1990. ASMR slightly increased from 43.10 (95% UI: 21.29–67.60) per 100,000 in 1990 to 44.97 (95% UI: 23.22–69.89) per 100,000 in 2021, with an AAPC of −0.47 (95% CI −0.83 to −0.10). ASDR decreased from 385.65 (95% UI: 129.83–647.51) per 100,000 in 1990 to 335.59 (95% CI: 112.75–566.25) per 100,000 in 2021, with an AAPC of −0.49 (95% CI −0.83 to −0.10). Stratified by gender, ASMR significantly increased by 9.75% in men (from 48.82 per 100,000 to 58.57 per 100,000), while it decreased by −3.96% in women (from 38.91 per 100,000 to 34.95 per 100,000). The burden of disease increased sharply with age from 1990 to 2021. The period effect showed that mortality and DALYs increased from 1990 to 2009 and then decreased after 2010. The cohort effect indicated that women born before 1940 had a higher burden, while the risk for men continued to rise after 1940. The ARIMA model's prediction indicates that by 2050, the age-standardized mortality rate (ASMR) of CVD caused by high LDL-C in China is expected to increase by 55.14%, and the age-standardized death rate (ASDR) will rise to 1873.18 per 100,000. Conclusion: The burden of CVD caused by high LDL-C in China increased overall from 1990 to 2021. The stratified results by gender indicated that the ASMR and ASDR of men were higher than those of women. Stratification by age showed that the burden was the greatest among people over 70 years old. This was mainly due to population growth, aging, and risk factors. The prediction shows that the disease burden will continue to rise until 2050, and men will remain a high-risk group. Given the continuous trend of population aging, it is necessary to consider various lipid-lowering strategies and the effective allocation of medical resources in the future to reduce the disease burden related to CVD caused by high LDL-C.

  • Open Access

    Validation of a novel CT perfusion software compared to RAPID in stroke patients receiving endovascular therapy

    by Dan Chen, Wenhuo Chen, Thanh N. Nguyen, Tingyu Yi, Luyun Zhang, Xinze Guo, Yanting Chang, Xue Bai, Bowen Deng, Yang Zhang, et al.

    Accurate estimate of ischemic core volume (ICV) and penumbra volume (PV) is important in decision-making for endovascular therapies (EVT) and predicting the patient’s clinical outcome. In this study, we compared the performance of a novel automated CT perfusion software UGuard and the Rapid Processing of Perfusion and Diffusion (RAPID). UGuard and RAPID had strong agreement with regard to ICV (ICC 0.92, 95% CI 0.89 – 0.94) and PV (ICC 0.8, 95% CI 0.73 – 0.85) measurements. ICVs measured by UGuard or RAPID were similar in predicting favorable outcome (AUC 0.72 vs. 0.70, P = 0.43), with UGuard measurements having higher specificity. After adjusting for significant clinical covariates, the predictive performance of favorable outcome was excellent for each of the six models incorporating ICV and PV, and the model which incorporated ICV and PV measured by UGuard software package showed the best predictive performance. We concluded that the ICV and PV of CT perfusion images measured by UGuard software package, as well as the capacity to predict favorable outcome of patients following EVT, were comparable to RAPID.


  • Open Access

    Construction and validation of coronary heart disease risk prediction model for general hospitals in Tacheng Prefecture, Xinjiang, China

    by Yikang Xu, Jingru Ma, Yang Yang, Limin Liu, Xinran Zhao, Yu Wang, Alimu Mijiti, Qiangru Cheng, Jun Ma, \R\Nyikang Xu

    Objective: To analyze the risk factors for coronary heart disease (CHD) in patients hospitalized in general hospitals in the Tacheng Prefecture, Xinjiang, and to construct and verify the nomogram prediction model for the risk of CHD.Methods: From June 2022 to June 2023, 489 CHD patients (CHD group) and 520 non-CHD individuals (control group) in Tacheng, Xinjiang, were retrospectively selected. Using a 7:3 ratio, patients were divided into a training group (706 cases) and a validation group (303 cases). General clinical data were compared, and key variables were screened using logistic regression (AIC). A CHD risk nomogram for Tacheng was constructed. Model performance was assessed using ROC AUC, calibration curves, and DCA.Results: In the training group, non-Han Chinese (OR = 2.93, 95% CI: 2.0–4.3), male (OR = 1.65, 95% CI: 1.0–2.7), alcohol consumption (OR = 1.82, 95% CI: 1.2–2.9), hyperlipidemia (OR = 2.41, 95% CI: 1.7–3.5), smoking (OR = 1.61, 95% CI: 1.0–2.6), diabetes mellitus (OR = 1.62, 95% CI: 1.1–2.4), stroke (OR = 2.39, 95% CI: 1.6–3.7), older age (OR = 1.08, 95% CI: 1.1–1.2), and larger waist circumference (OR = 1.04, 95% CI: 1.0–1.1) were the risk factors for coronary heart disease (all P < 0.05). The area under the curve (AUC) of the work characteristics of the subjects in the training group and the validation group were 0.80 (95% CI: 0.8–0.8) and 0.82 (95% CI: 0.8–0.9), respectively. The Hosmer-Lemeshow test indicated P = 0.325 for the training group and P = 0.130 for the validation group, with calibration curves closely fitting the ideal curve. The predicted values aligned well with actual values, and decision curve analysis results suggest that the model offers a net clinical benefit.Conclusion: The CHD risk prediction model developed in this study for general hospitals in Tacheng Prefecture, Xinjiang, demonstrates strong predictive performance and serves as a simple, user-friendly, cost-effective tool for medical personnel to identify high-risk groups for CHD.


  • Open Access

    Prognostic prediction of m6A and ferroptosis-associated lncRNAs in liver hepatocellular carcinoma

    by Yuchen Gao, Jingxiao Li, Mingyue Ma, Wenting Fu, Lin Ma, Yi Sui, Yu Wang

    Article Prognostic prediction of m6A and ferroptosis-associated lncRNAs in liver hepatocellular carcinoma was published on November 1, 2024 in the journal Journal of Translational Internal Medicine (volume 12, issue 5).